Hi, I am Harsha Rajasimha, Founder and CEO of Jeeva from Virginia. We are a B2B eClinical SaaS Platform for clinical researchers, sponsors, sites, and CROs to accelerate their clinical trial timelines.
Unlike the competition, Jeeva’s patent-pending platform is AI-driven, offers single login for all users from any browser-enabled mobile device without requiring special hardware infrastructure while delivering a superior user experience. 85% of trials are delayed and 30% of them terminate due to poor patient enrollment. Every day delayed causes a revenue loss of $600K to 8M to the sponsor.
The eClinical solutions market is estimated at $16B by 2027 with 30K new trials starting each year. Pandemic-driven decentralization is in favor of driving the rapid adoption of our proprietary modular platform particularly for smaller customers with >60% profit margins. With a validated business model, referenceable customers, recent revenue flow, and a strong leadership team in place backed by an industry-leading advisory board, investors, and partners. With $1.9M raised including 300K Govt grants, we are seeking a $700K investment to achieve $1M ARR leading to a Series A next year. I am inspired by my younger brother with Juvenile diabetes who passed away in India in 2017 while I was pursuing my dreams in the US. I invite you to join us in enabling remote access to clinical trials globally!